Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Varex ImagingFRA:VI4 66 EV-to-EBITDA is 12.93 as of Aug. 18, 2026, which is 8% below its 10-year median of 14.00. GuruFocus rates FRA:VI4 with a GF Score™ of 66/100 and a GF Value™ of €11.23. The stock has 6 warning signs investors should review. Among 513 Medical Devices & Instruments companies, Varex Imaging ranks better than 56.34% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Varex Imaging's enterprise value is €922.1 Mil.
Varex Imaging's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was €71.3 Mil. Therefore, Varex Imaging's EV-to-EBITDA for today is 12.93.
The historical rank and industry rank for Varex Imaging's EV-to-EBITDA or its related term are showing as below:
FRA:VI4'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -177.83 Med: 14 Max: 959.12
Current: 12.86
During the past 13 years, the highest EV-to-EBITDA of Varex Imaging was 959.12. The lowest was -177.83. And the median was 14.00.
FRA:VI4's EV-to-EBITDA is ranked better than 56.34% of 513
companies
in the Medical Devices & Instruments industry
Industry Median: 14.83
vs FRA:VI4: 12.86
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Varex Imaging's PE Ratio (TTM) for today is calculated as:
Varex Imaging's share price for today is €15.80.
Varex Imaging's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.447.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Varex Imaging's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:VI4 vs OFIX, VMD, KIDS: EV-to-EBITDA Comparison
For the Medical Devices subindustry, Varex Imaging's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Varex Imaging EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Varex Imaging's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Varex Imaging's EV-to-EBITDA falls into.
Varex Imaging's current Enterprise Value is €922.1 Mil.
Varex Imaging's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €71.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Varex Imaging (FRA:VI4) has a EV-to-EBITDA of 12.93 as of Aug. 18, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Varex Imaging. This is near median its historical median of 14.00. According to the industry distribution chart, Varex Imaging ranks #224 out of 513 companies in the Medical Devices & Instruments industry, placing it in the top 43.7%.
Is Varex Imaging's EV-to-EBITDA too high?
Varex Imaging's current EV-to-EBITDA of 12.93 is near median its 10-year median of 14.00. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.83. Varex Imaging's value of 12.93 is 12.8% below this industry median. Based on the distribution chart, Varex Imaging ranks #224 out of 513 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Varex Imaging has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Varex Imaging's EV-to-EBITDA compare to OFIX and VMD?
According to the Medical Devices & Instruments industry distribution chart, Varex Imaging ranks #224 out of 513 companies for EV-to-EBITDA. This puts Varex Imaging in the upper half of its industry. The industry median EV-to-EBITDA is 14.83. Varex Imaging's value of 12.93 is 12.8% below this benchmark. While the company's 10-year median is 14.00 vs. the industry median of 14.83, Varex Imaging has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.83, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Varex Imaging's current EV-to-EBITDA of 12.93 is 12.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Varex Imaging. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Varex Imaging's current EV-to-EBITDA is 12.93, which is near median its own 10-year median of 14.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Varex Imaging stock overvalued right now?
Varex Imaging (FRA:VI4) has a current EV-to-EBITDA of 12.93. The stock's GF Value™ is €11.23, compared to a current price of €15.80 — trading 40.7% above its estimated fair value. The current EV-to-EBITDA is 12.93, which is near median its 10-year median of 14.00 and 12.8% below the Medical Devices & Instruments industry median of 14.83. Varex Imaging's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Varex Imaging (FRA:VI4), the current EV-to-EBITDA is 12.93 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Varex Imaging (FRA:VI4) Overvalued in 2026?
Based on GuruFocus' analysis, Varex Imaging stock appears to be overvalued.
The current stock price of €15.80 is trading 40.7% above its estimated GF Value™ of €11.23.
Key valuation signals for FRA:VI4:
EV-to-EBITDA: 12.93 (near median its 10-year median of 14.00)
GF Value™: €11.23 vs. price of €15.80 (40.7% above fair value)
Industry Position: 12.8% below the Medical Devices & Instruments median (#224 of 513)
No single metric tells the full story. See the FRA:VI4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
66GF Score
Get the complete analysis for FRA:VI4
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:VI4 has been successfully added to your 
